n = 135 | ||
---|---|---|
Frequency (%) | ||
Age | Mean (SD) | 65.3a (8.5a) |
Range | 47-85 | |
Marital status | Single | 8 (5.9%) |
Partnership, marriage | 70 (51.9%) | |
Divorced, separated | 20 (14.8%) | |
Widowed | 18 (13.3%) | |
Employment status | Full time | 7 (5.2%) |
Part time | 9 (6.7%) | |
Unemployed | 3 (2.2%) | |
Homemaker | 18 (13.3%) | |
Retired | 76 (56.3%) | |
Other | 3 (2.2%) | |
Diagnosis | in situ | 13 (9.6%) |
invasive | 121 (89.6%) | |
Duration of adjuvant endocrine therapy (months) | Mean (SD) | 29.5 (17.3) |
Range | 2.5-70.8 | |
Primary surgical treatment | Breast conserving surgery | 87 (64.9) |
Mastectomy | 47 (35.1) | |
Chemotherapy | yes | 27 (20%) |
Radiotherapy | yes | 98 (72.6%) |
BMI | Mean (SD) | 25.2 (4.3) |
Median | 25.2 | |
range | 19.5-43.7 | |
Estradiol | ≤12 | 119 (88.1%) |
>12 | 16 (11.9%) | |
Median | 12 ng/L | |
Minimum-Maximum | <12 -69 ng/L | |
LH | Mean (SD) | 26.5 (10.2) |
Median | 25.6 U/L | |
Minimum-Maximum | 0.1-62.10 U/L | |
range | 62 U/L | |
FSH | Mean (SD) | 83.3 (28.0) U/L |
Median | 81.4 U/L | |
Minimum-Maximum | 26.40-188 U/L | |
range | 161.6 U/L | |
SHBG | Mean (SD) | 50.3 (20.2) nmol/l |
Median | 45.5 nmol/l | |
Minimum-Maximum | 12.3-116 nmol/l | |
range | 103.7 nmol/l |